INVITE YOUR STAFF Date: Tuesday, August 9 Time: 7:00 to 7:30 AM ET Call: 800 930 9863, pass code 21526#

BALTIMORE, MD—August 6, 2011—Enrollment is now open for a complimentary, case-based Community of Practice audioconference to address the challenges of treating patients with triple-negative breast cancer (TNBC).

Oncologists, hematologists, and other clinicians who treat patients with TNBC can speak with faculty expert Edith A. Perez, MD, of Mayo Clinic’s Comprehensive Cancer Center, in this live interactive discussion on Tuesday, August 9 at 7:00 AM ET. This educational activity will provide participants across the country with the opportunity to review methods for effectively overcoming practice barriers in TNBC care.

FACULTY

Edith A. Perez, MD Deputy Director, Mayo Clinic's Comprehensive Cancer Center Serene M. and Frances C. Durling Professor of Medicine Mayo Clinic Jacksonville, FL

TNBC accounts for 15% to 20% of breast cancer diagnoses and is highly prevalent among young women, particularly premenopausal African Americans. An increased awareness of TNBC, including a concrete understanding of tumor characteristics at the molecular level, is critical to help clinicians improve the detection, diagnosis, prevention, and treatment of this malignancy.

"During this complimentary audioconference, you will have the opportunity to ask me about TNBC treatment strategies," said Edith A. Perez, MD. "I look forward to leading this collaborative forum and hope to speak with you soon."

Clinicians interested in joining this complimentary Community of Practice audioconference can call (toll-free) 800 930 9863 (pass code 21526#) on Tuesday at 7:00 AM ET.

This audioconference was developed in association with the complimentary, case-based CME/CE Webcast, TNBC: Translating Clinical Research Into Optimal Patient Care. Ruth M. O'Regan, MD, of Emory University School of Medicine’s Winship Cancer Institute, joins Dr. Perez in presenting this interactive Webcast which reviews triple-negative tumor histology, the associated clinical risk, and existing and emerging strategies to address the challenges of treating this condition.

This series is sponsored by Med-IQ, an ACCME-accredited provider of CME, and supported by an educational grant from sanofi-aventis U.S.

About Med-IQ

Med-IQ, recipient of the Alliance for CME’s 2011 William Campbell Felch Award for Research in CME, is an accredited provider of education that inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. We are a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives. To learn more about Med-IQ, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.

For more information, contact:

Catherine B. Mullaney, MHA
Vice President, Educational Partnerships
Med-IQ
443 543 5101
info@med-iq.com

Join our social network for real-time medical education best practices.